Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2013 / Cilt: 47 - Sayı: 1

Angioedema: Diagnosis and treatment approaches

Anjiyoödem: Tanı ve tedavi yaklaşımları

Pages
7–18
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, common and rare forms as well as clinical symptoms, differential diagnosis, and treatment approaches for AE are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Angioedema (AE) is defined as sudden, localized and transient swelling of the skin and/or mucous membranes.
📊
Key Findings & Data:There are several forms including those involving dysfunction or depletion of the C1-inhibitor gene (classical hereditary AE types and acquired AE), allergic AE, drug-induced AE (nonsteroidal anti-inflammatory drug-induced AE, angiotensin converting enzyme inhibitor-induced AE), idiopathic and a recently described form, HAE type 3.
💡
Conclusion & Impact:In this article, common and rare forms as well as clinical symptoms, differential diagnosis, and treatment approaches for AE are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Angioedema (AE) is defined as sudden, localized and transient swelling of the skin and/or mucous membranes. This swelling condition is a result of interstitial edema from vasoactive mediators increasing the permeability of postcapillary venules of the subcutaneous and submucosal tissues. When localized to the skin, it presents as asymmetric, nonpitting, nondependent, and occasionally painful edema. However, mucosal attacks, such as laryngeal edema and bowel involvement can produce severe discomfort and life-threatening symptoms. There are several forms including those involving dysfunction or depletion of the C1-inhibitor gene (classical hereditary AE types and acquired AE), allergic AE, drug-induced AE (nonsteroidal anti-inflammatory drug-induced AE, angiotensin converting enzyme inhibitor-induced AE), idiopathic and a recently described form, HAE type 3. These various forms of AE have overlapping symptoms, but some unique clinical and historical features as well as presence of accompanying urticaria can aid in the differential diagnosis. The key to successful management is to rule out conditions that masquerade as AE, detection and avoidance of triggers, early recognition of attacks, and aggressive airway management when warranted. In this article, common and rare forms as well as clinical symptoms, differential diagnosis, and treatment approaches for AE are reviewed.

Özet

Anjiyoödem (AE) deri ve/veya mukozaların ani başlangıçlı geçici lokalize ödemi olarak tanımlanır. Bu şişme tablosu subkutan ve submukozal dokulardaki postkapiller venüllerin geçirgenliğini arttıran çeşitli vazoaktif mediyatörlerin aracılığıyla oluşan interstisyal ödem sonucunda meydana gelir. Deriye lokalize olduğunda asimetrik, gode bırakmayan, yer çekimiyle yer değiştirmeyen ve bazen ağrılı olabilen şişme ile karakterizedir. Bununla birlikte laringeal ödem ve barsak tutulumu gibi mukozal ataklar şiddetli rahatsızlığa ve hayati tehlike oluşturan semptomlara yol açabilir. Çeşitli AE formları arasında C1 inhibitör geninin disfonksiyonu veya eksikliği ile ilişkili AE (klasik herediter AE tipleri ve edinsel AE), allerjik AE, ilaçlarla ilişkili AE (steroid dışı antiinflamatif ilaçlara bağlı AE, anjiyotensin dönüştürücü enzim inhibitörlerine bağlı AE), idiyopatik AE ve yakın zamanda tanımlanan tip 3 herediter AE bulunmaktadır. Bu değişik AE formlarında örtüşen semptomlar olabilmekle birlikte bazı özgün klinik ve öykü özellikleri yanında eşlik eden ürtikaryanın varlığı ayırıcı tanıda yardımcı olabilir. AE benzeri tabloları dışlamak, tetikleyici faktörleri saptamak ve uzaklaştırmak, atakları erken farketmek ve gerekli olduğunda agresif solunum yolu açıklığını sağlamak başarılı tedavinin temelini oluşturur. Bu makalede AE’nın sık ve nadir görülen formları yanında klinik semptomları, ayırıcı tanıları ve tedavi yaklaşımları derlenmiştir.

🔖

Cite This Article

AKARSU, S., GÜNEŞ, A. T. (2022). Angioedema: Diagnosis and treatment approaches. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 47 - Sayı: 1, 7–18. https://ajindex.com/articles/621887

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Kaplan AP, Greaves MW: Angioedema. J Am Acad Dermatol 2005;53:373-88
  2. Kanani A, Schellenberg R, Warrington R: Urticaria and angioedema. Allergy Asthma Clin Immunol 2011;7(Suppl 1):9
  3. Temiño VM, Peebles RS Jr: The spectrum and treatment of angioedema. Am J Med 2008;121:282-6
  4. Busse PJ: Angioedema: differential diagnosis and treatment. Allergy Asthma Proc 2011;32 (Suppl 1):3-11
  5. Grigoriadou S, Longhurst HJ: Clinical Immunology Review Series: An approach to the patient with angio-oedema. Clin Exp Immunol 2009;155:367-77
  6. Caballero T, Baeza ML, Cabañas R, et al: Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 2011;21:333-47
  7. Lipozenci J, Wolf RLife-threatening severe allergic reactions: urticaria, angioedema, and anaphylaxis. Clin Dermatol 2005;23:193-205
  8. Bork K: Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006;26:709-24
  9. Greenberger PA: Anaphylactic and anaphylactoid causes of angioedema. Immunol Allergy Clin North Am 2006;26:753-67
  10. Frigas E, Park M: Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 2006;26:739-51
  11. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD: Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001;45:387-91
  12. Heymann WR: Chronic urticaria and angioedema associated with thyroid autoimmunity: review and therapeutic implications. J Am Acad Dermatol 1999;40:229-32
  13. Wisnieski JJ, Baer AN, Christensen J, et al: Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore) 1995;74:24-41
  14. Zuraw BL: Clinical practice. Hereditary angioedema. N Engl J Med 2008;359:1027-36
  15. Zuraw BL, Herschbach J: Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 2000;105:541-6
  16. Weis M: Clinical review of hereditary angioedema: diagnosis and management. Postgrad Med 2009;121:113-20
  17. Bowen T, Cicardi M, Farkas H, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010;6:24
  18. Nagy N, Grattan CE, McGrath JA: New insights into hereditary angio- oedema: Molecular d